Horizon Therapeutics Public Limited Company (HZNP)

77.44
1.38 1.81
NASDAQ
Prev Close 76.06
Open 75.94
Day Low/High 75.94 / 78.04
52 Wk Low/High 23.81 / 86.67
Volume 2.03M
Exchange NASDAQ
Shares Outstanding 211.41B
Market Cap 15.70B
P/E Ratio 26.06
Div & Yield N.A. (N.A)

Latest News

Here's How I'm Positioning Myself Into the Surprise Gap Up

Here's How I'm Positioning Myself Into the Surprise Gap Up

While I'm reducing some of my bigger positions into strength, I'm definitely not bearish.

Traders Focused on Bounces Have Made Some Quick Exits Already

Traders Focused on Bounces Have Made Some Quick Exits Already

This isn't a market with a lot of very extended stocks so the chances of catching some names at support are good.

This Is Great Action for Stock Pickers Right Now

This Is Great Action for Stock Pickers Right Now

Stick to themes like biotechnology, SPACs, EV batteries, and others.

My Shopping List Amid This Selloff

My Shopping List Amid This Selloff

Don't be in a rush. The key to accumulating stocks in this environment is to move incrementally.

The Indices Are Doing a Poor Job of Reflecting What's Really Going On

The Indices Are Doing a Poor Job of Reflecting What's Really Going On

Here are several names I'm looking to build on further weakness.

Reactive Bulls Are Still Topping Anticipatory Bears

Reactive Bulls Are Still Topping Anticipatory Bears

There are some concerns in the price action but dip buyers keep stepping up very quickly.

Celebrating the Greatness of Individual Traders

Celebrating the Greatness of Individual Traders

Good individual traders will produce returns far in excess of anything that traditional Wall Street will earn.

VMware and Chevron Are Among 11 Well-Known Stocks Ready to Change Direction

VMware and Chevron Are Among 11 Well-Known Stocks Ready to Change Direction

These names are showing bullish and bearish technical patterns over the past week.

Horizon Shares Rise on Q3 Results, Guidance -- Biotech Movers

Horizon Shares Rise on Q3 Results, Guidance -- Biotech Movers

The Dublin firm on Nov. 6 unveiled third-quarter numbers that topped analysts' estimates and raised its full-year net sales outlook and the lower end of its 2017 adjusted Ebitda guidance.

Closing Bell: Volatility at Lowest Since 1993; Pershing Backs Howard Hughes

Closing Bell: Volatility at Lowest Since 1993; Pershing Backs Howard Hughes

Volatility sank to its lowest level since 1993 to begin the new week as indexes held close to their flatlines.

Bears Are Losing Their Grip on Horizon Pharma

Bears Are Losing Their Grip on Horizon Pharma

The stock is slowly building a bullish setup.

Horizon Pharma Tanks on Failed Late-Stage Study

Horizon Pharma Tanks on Failed Late-Stage Study

Horizon's nueromuscular disorder treatment trials failed.

How Do the Charts Look for Jim Cramer's Weekly Shopping List?

How Do the Charts Look for Jim Cramer's Weekly Shopping List?

No matter who wins the election, there are ways to make money.

Closing Bell: Fed's Brainard Cautions 'Prudence'; U.S. Stocks Soar

Closing Bell: Fed's Brainard Cautions 'Prudence'; U.S. Stocks Soar

Relief flooded Wall Street after a number of Fed speakers took a dovish turn following increasingly hawkish rhetoric.

Tweets on the Street: Pimco's Eurozone Concerns, Shkreli on Horizon Pharma

Tweets on the Street: Pimco's Eurozone Concerns, Shkreli on Horizon Pharma

Social media chatter also included takes by Michael Bloomberg and Warren Buffett on small-business success.

A Move Lower Is on the Horizon (Pharma)

A Move Lower Is on the Horizon (Pharma)

Don't be surprised if HZNP trends lower to next chart support around $10.

Horizon Pharma Needs a Health Check

Horizon Pharma Needs a Health Check

HZNP could work lower to $10 in the weeks and months ahead.

Cramer: Collateral Damage Is Giving These Stocks a Bad Name

Cramer: Collateral Damage Is Giving These Stocks a Bad Name

But for the brave, they could offer a solid bottom-fishing opportunity.

Jim Cramer Recommends Ford Over General Motors Among Autos

Jim Cramer Recommends Ford Over General Motors Among Autos

Automakers are reporting sales results today, and Ford is Jim Cramer’s top pick in the auto sector.

Silly Season Continues for Biotech

Silly Season Continues for Biotech

Valuations of some small-cap concerns, such as Relypsa, are ridiculously cheap.

With Martin Shkreli Long Gone, Retrophin is an 'Interesting Opportunity'

With Martin Shkreli Long Gone, Retrophin is an 'Interesting Opportunity'

Retrophin (RTRX), the biotech company that used to be run by indicted hedge fund manager Martin Shkreki, provides an interesting investment opportunity.

Jim Cramer Says Don't Rush in to Buy Stocks in Monday Selloff

Jim Cramer Says Don't Rush in to Buy Stocks in Monday Selloff

Jim Cramer says don’t rush into the stock market in Monday's trading session looking for bargains in the midst of a selloff.

Bah Humbug Macy's, Jim Cramer Says the Holiday Season Belongs to Amazon

Bah Humbug Macy's, Jim Cramer Says the Holiday Season Belongs to Amazon

Jim Cramer, portfolio manager at TheStreet’s Action Alerts PLUS and host of CNBC’s ‘Mad Money’ said Amazon (AMZN) stock is going higher because the company’s business model is so good.

Why Biotech Has Bottomed

Why Biotech Has Bottomed

Investors should ignore the temporary issues that have knocked the sector down.